Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity
Cagrilintide Reconstitution Cagrilintide - dose per draw at common vial sizes Vial Size 5 mg BAC Water 2.0 mL Concentration 2.5 mg/mL 0.25 mg 0.10 mL (10 units) 0.5 mg 0.20 mL (20 units) 1.0 mg 0.40 mL (40 units) 2.4 mg 0.96 mL (96 units) Vial Size 10 mg BAC Water 2.0 mL Concentration 5.0 mg/mL 0.25 mg 0.05 mL (5 units) 0.5 mg 0.10 mL (10 units) 1.0 mg 0.20 mL (20 units) 2.4 mg 0.48 mL (48 units) Vial Size 10 mg BAC Water 1.0 mL Concentration 10.0 mg/mL 0.25 mg 0.025 mL (2.5 units) 0.5 mg 0.05 mL (5 units) 1.0 mg 0.10 mL (10 units) 2.4 mg 0.24 mL (24 units) Cagrilintide is sensitive - inject BAC water down the vial wall and swirl gently
Future research should investigate synergistic and selective effects of various activators within multi-target regulatory networks to optimize clinical applicability
[Crossref] Editorial Information Editor-in-Chief Chin-Lung Kuo Taoyuan Armed Forces General Hospital Taiwan Article Type Research Article Publication history Received date: April 02, 2021 Accepted date: April 16, 2021 Published date: April 21, 2021 Copyright 2021 Gamboa JDM
That makes it one of the most-studied peptides in the entire preclinical (= preclinical testing prior to clinical trials) regenerative literature
